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Discovery and origin of microglia 
Microglial cells are the resident tissue macrophages of the central nervous system (CNS) of 
which the origin has been a long and extensively debated subject over the past one and a half 
century. In 1856, pathologist Rudolf Virchow introduced the term neuroglia, or nerve glue, to 
describe cells forming a tissue environment in which nervous elements were embedded 
(Virchow, 1856). In 1919 Pio del Rio Hortega introduced the term microglia and described in 
the 1930’s that these mesodermal, amoeboid cells invade the brain at early development and 
adopt a branched, ramified morphology in the maturing brain (Ginhoux et al., 2013; 
Kettenmann et al., 2011; Rezaie and Male, 2002). Although already described by Pio del Rio 
Hortega as cells of mesodermal origin, it was shown only in the 1990’s that transgenic mice 
with a disrupted PU.1 gene, a specific marker for myeloid cells, completely lack microglia 
(McKercher et al., 1996). Furthermore, microglia were shown to express this specific marker 
(Walton et al., 2000). At present, microglia are considered to be of myeloid origin and only 
recently the specific origin of microglial progenitors has been identified. Microglia derive from 
primitive myeloid progenitors in the yolk sack that colonize the CNS during early embryonic 
development. This site of origin is well conserved between species as shown in zebrafish, avian, 
rodents and humans. In the brain, microglia form a self-renewing population independent of 
replenishment from the periphery (Ginhoux et al., 2013, 2010).  Recently, Elmore et al (2014) 
showed the high efficiency with which microglia can repopulate the brain. With a sophisticated 
method using colony stimulating factor 1 receptor (CSF1R) inhibitors they were able to 
eliminate~99% of the microglia population in the brain. More remarkably, they show that after 
withdrawal of CSF1R inhibitors microglia repopulate the brain within one week. This happens 
through proliferation of and differentiation of nestin-positive cells into microglia throughout 
the CNS (Elmore et al., 2014). These repopulated microglia did not show differences to resident 
microglia when an inflammatory stimulus, lipopolysaccharide (LPS) was applied to mice nor 
did mice with repopulated microglia perform differently in behavioral and cognitive tasks 
(Elmore et al., 2015). 
Microglia in the healthy brain 
Until recently, the main function of microglia was considered to be activation during 
pathological events, where a shift takes place from a quiescent or ‘resting’ morphology to a 
more amoeboid ‘activated’ morphology. It is in this activated state that microglia initiate 
executive programs resulting in production and secretion of cytokines, chemokines and 




activation of microglia under pathological conditions is of major importance, discoveries in the 
past decade show that it is certainly not the only role for microglia in brain physiology. 
 
Microglia are dynamic sensors 
 
A discovery of major importance for our view of microglia were simultaneous reported by 
Nimmerjahn et al (2005) and Davalos et al (2005) using intravital 2-photon microscopy. 
‘Resting’ microglia are actually extremely dynamic with motile processes and protrusions 
which make transient contacts with astrocytes, neurons and blood vessels. These observations 
indicate that microglia are constantly monitoring brain homeostasis and are enabled to scan the 
total brain parenchyma in just several hours (Davalos et al., 2005; Nimmerjahn et al., 2005). It 
was hypothesized that in this way microglia sense minor disturbances in the CNS and directly 
resolve them, to maintain a steady brain homeostasis (Hanisch and Kettenmann, 2007). From 
this point on, more research started focusing on basal microglia functions at developmental 
stages of the brain as well as in healthy adult brain. 
 
 
Microglia shape neuronal circuits 
 
It has become clear that processes which were originally related to pathological conditions are 
of major importance in maintaining a healthy brain environment. Upon synaptic stripping, 
which was first reported in 1968, after cutting the right facial nerve of rats, microglia were 
found in close proximity with the soma and main dendrites of motor neurons. It was observed, 
by electron microscopy, that morphological intact synaptic terminals were removed but at this 
time the significance of this process could not yet be clarified (Blinzinger and Kreutzberg, 
1968). Now, 4 decades later, the importance of microglia ´stripping´ synaptic elements is 
considered paramount for shaping neuronal circuitry during development and maintenance of 
neuronal plasticity during adulthood. However, the molecular pathways how microglia regulate 
synapse networks processes are not fully understood (Kettenmann et al., 2013). Microglia are 
able to sense neuronal activity using a range of receptors for neurotransmitters, neuropeptides 
and neuromodulators. During postnatal development, a large amount of synaptic connections 
are made by neurons at an amount far higher than the number required for mature brain 
physiology. Subsequently, neuronal circuitries are formed by activity-dependent elimination of 
immature synapses by microglia, a process called synaptic pruning (Paolicelli et al., 2011; 
Schafer et al., 2012). Mice that lack the CX3CR1 chemokine receptor, a receptor specific for 





How microglia recognize specific immature synapses that have to be eliminated, is not fully 
understood. One proposed mechanism is the presence of the complement C3 on immature 
synapses that is recognized by C3 receptors like Cd11b on microglia (Schafer et al., 2012).  
In the healthy adult brain, microglia also play an important role in the neurogenic cascade. 
Within the subgranular zone (SGZ) in the hippocampus, progenitor cells give rise to neural 
precursor cells, which integrate into the hippocampal neuronal circuitry. In this process of 
neurogenesis, unchallenged microglia efficiently phagocytose apoptotic newborn cells. This 
phagocytosis does not lead to microglial activation of the microglia itself, suggesting that it is 
a basal homeostatic function of microglia (Sierra et al., 2010).  
Microglia activation pathways 
Pattern recognition receptor-mediated activation 
 
Activation of microglia can be initiated by the signaling of pattern recognition receptors 
(PRRs), which sense highly conserved molecular patterns or sequences present in pathogenic 
microbes and are referred to as pathogen associated molecular patterns (PAMPs). PRRs can 
also sense endogenous cell content released by damaged cells, which are referred to as danger 
associated molecular patterns (DAMPs). At present, 4 PRR families are identified and include 
C-type lectin receptors (CLRs), Retinoic acid-inducible gene (RIG)-I-like receptors, NOD-like 
receptors (NLRs) and Toll-like receptors (TLRs; Kigerl et al., 2014; Saijo et al., 2013). These 
receptor families are all expressed by microglia and play a significant role in neuroimmune 
responses.  
C-type lectin receptors 
 
C-type lectin receptor CD209b/SIGN-R1 is expressed on microglia but not astrocytes and 
neurons in rat brain. It mediates the complement activation pathway against Streptococcus 




(RIG)-I-like receptors, of which retinoic acid-induced gene 1 (RIG-1) and melanoma 
differentiation-associated gene 5 are mostly expressed by microglia and astrocytes, recognize 
double stranded viral RNA in the cytoplasm leading to type-1 interferon and pro-inflammatory 
cytokine release. These receptors are implicated in antiviral responses against for example West 







Of the NLR receptor family, NLRP3 and NOD2 amongst others are primarily expressed in the 
CNS by microglia. NOD2 is implicated in bacterial danger signal (MDP) induced activation of 
NF-B leading to pro-inflammatory cytokine production and recognition of viral ssRNA, 
leading to IRF-3 signaling and release of type-I interferons. Recognition of PAMPS and 
DAMPS leads to the assembly of the inflammasome complex, initiated by NLRs or ‘absent in 
melanoma 2’ (AIM2) like receptors, which recognize them (fig.1). The moment NLRs are 
activated, apoptosis-associated speck-like protein (ASC) is recruited which contains a caspase 
activation- and recruitment domain. Thus, in case of NLRP, the assembled inflammasome 
contains NLRP3, ASC and procaspase 1 (Man and Kanneganti, 2015; Shao et al., 2015). In the 
presence of immune activators interaction between NLRP3 and ASC isinitiated  and serves as 
a trigger for formation of a large multimeric ASC protein complex. Thereafter, ASC recruits 
pro-caspase 1 monomers, eventually leading to self-cleavage of pro-caspase 1 into active 
caspase 1 which in turn can lead to proteolytic cleavage of pro-IL1 and pro-IL18 (Latz et al., 
2013; Man and Kanneganti, 2015; Shao et al., 2015). Activation of the NLRP3 inflammasome 
occurs in a two-step fashion. As the initial step priming takes place by recognition of PAMPs 
or DAMPS by TLRs which leads to activatedNF-B induced transcription of inflammasome 





inflammasome assembly and activation induced by a second signal. Several mechanisms for 
this subsequent inflammasome activation (signal 2) have been proposed. Amongst them ATP-
induced K+ efflux through P2X7 receptor activation which also involves disturbed Ca2+ fluxes, 
PAMPs and DAMPs induced (mitochondrial) ROS and phagocytosis of environmentl irritants 
leading to lysosomal rupture and release of lysosonal content such as cathepsin B (Fig.1) 
(Lampron et al., 2013; Latz et al., 2013; Man and Kanneganti, 2015; Shao et al., 2015). 
 
 
Toll like receptors 
 
A group of PRRs especially important for microglia activation is the family of Toll like 
receptors, which play a paramount role in the innate as well as the adaptive immune response. 
The Toll signaling pathway was initially identified in Drosophila melanogaster, where it was 
discovered to be important for dorsal-ventral patterning of the embryo. Subsequently, it became 
apparent that this pathway was important in the immune response of Drosophila (Valanne et 
al., 2011). Just shortly after, the first mammalian TLR was described in 1997, when Medzhitov 
et al (1997) cloned a human homologue of Drosophila Toll protein and showed that human cell 
lines transfected with the active mutant of human Toll showed activation of the NF-B pathway 
and induction of NF-B controlled pro-inflammatory genes (Medzhitov et al., 1997). In mice 
and humans, 13 and 11 TLR receptor family members are identified, respectively. Similar to 
other tissues in the body, the TLR receptors (in different repertoires) in the brain are expressed 
by every glial cell type and neurons (Hanke and Kielian, 2011). It is noteworthy that microglia 
express every type of TLR receptor known, emphasizing the vital role these cells play in 
immune responses. TLR receptors can be divided into two groups depending on their 
localization, TLR1, TLR2, TLR4, TLR5 and TLR6 are expressed as transmembrane receptors, 
and TLR3, TLR7, TLR8 and TLR9 are expressed on intracellular endosomes (Kigerl et al., 
2014). At present, TLR2 and TLR4 have been characterized most extensively, recognizing 
microbial motifs, peptidoglycan, lipoproteins, dectin and lipopolysaccharide (Hanke and 
Kielian, 2011). The first ligand that was identified for TLRs was lipopolysaccharide, an outer 
cell wall component of gram-negative bacteria, as a TLR4 ligand (Poltorak et al., 1998). The 
Figure 1 Activated inflammasome cleave pro-IL-1and pro-IL18 to bioactive cytokines IL-
1and IL18.  Assembly and activation of the NLRP3 inflammasome complex happens in two 
steps. 1) recognition of PAMPs/DAMPs by TLR receptors that leads to Nf-κB induced 
transcription of inflammasome components and pro-IL-1and pro-IL18. 2) a second signal such 
as K+ efflux through the P2X7 receptor (1), mitochondrial ROS (2) or environmental irritants (3) 






importance for the immunology field of this discovery was highlighted by the fact that the 
Nobel prize was awarded for this work. Stimulation with LPS is a widely used model to study 




Signal transduction by TLRs is mediated through MYD88-dependent and TRIF-dependent 
pathways. All TLRs signal via MYD88, except TLR3 which exclusively signals through TRIF. 
Cell surface TLRs and endosomal TLRs utilize distinct activation mechanisms leading to quite 
similar signaling outcomes (fig.2) (Gay et al., 2014). For LPS-induced TLR4 activation, CD14 
binds LPS, among other ligands such as lipoproteins, in a hydrophobic pocket and transfers 
LPS to the TLR4 receptor complex. CD14 is present both as a cell surface glycoprotein linked 
by a glycosylphosphatidylinositol tail and as a soluble serum protein.  (Park and Lee, 2013). In 
addition to increase sensitivity of microglia to PAMP and DAMP challenges compared to 
peripheral macrophages, CD14 prevents an exaggerated response by an IFN mediated 







TLRs exist as monomers on the cell surface and are activated when active dimers are formed. 
Before successful transfer of LPS from CD14 to the TLR4 complex can happen, TLR4 needs 
to form heterodimeric complexes with the co-receptor myeloid differention factor 2 (MD2). 
Thereafter, the lipid A structure of LPS interacts with MD2 creating reaction interfaces by 
charge and hydrogen bond interactions, eventually leading to the dimerization and formation 
of an active TLR4/MD2/LPS complex (Gay et al., 2014; Lu et al., 2008; Park and Lee, 2013). 
It is hypothesized that when the extracellular domains form dimers, this leads to juxtaposition 
of the intracellular domains and are called Toll/IL-1R homology (TIR) domains, due to their 
homology to the interleukin-1 receptor (IL-1R) family. This structural change results in the 
creation of a platform which adaptor proteins recognize and bind to induce intracellular signal 
transduction (Miguel et al., 2007). Thus far, in total five adaptor proteins have been identified 
and TLR4 is the only known receptor to use all of them (O’Neill and Bowie, 2007). Myd88 is 
an essential element in the signaling  cascade of all TLRs with the exception of TLR3 that only 
utilizes TRIF dependent signaling (Takeuchi and Akira, 2010). During Myd88 dependent 
signaling, cytosolic Myd88 is recruited to the cell surface or endosomal plasma membrane by 
the sorting adaptor protein Myd88-adaptor like (Mal) which bridges Myd88 to the TIR (Ohnishi 
et al., 2009). In turn Myd88 contains in addition to its TIR domain also a death domain (DD) 
which allows interaction with DD containing kinases. Upon binding of LPS the IL-1 receptor-
associated kinase-4 (IRAK-4) is recruited and activated by Myd88 and a complex is formed 
with a stoichiometry of 7:4 or 8:4. Binding of IRAK-4 to Myd88 induces activation of IRAK-
Figure 2 TLR4 and TLR3 receptor signaling pathways. Transfer of LPS by CD14 to the TLR4 
receptor complex leads to the formation of an active TLR4/MD2/LPS complex. With that 
activation, common pathways to be activated are Myd88 or TRIF dependent signaling pathways. 
Mal bridges TIR domains of MYD88 and TLR4, IRAK4 in turn is recruited and activated by 
Myd88 inducing trans-autophosphorylation of IRAK4 which induces recruitment and activation 
or IRAK1 and/or IRAK2. IRAK-4 phosphorylates IRAK-2/1, inducing IRAK2/1 to leave the 
IRAK-4/2/1 complex and associate with TNF-α receptor-associated factor (TRAF) 6, Binding of 
IRAk-2/1 to TRAF6 leads to oligomerization of TRAF6, which in conjunction with E2 enzyme 
Ubc13/Uev1A catalyzes Lys63 (K63)-linked ubiquitination of TRAF6 itself and of target proteins 
IRAK1 and NEMO. K63-linked polyubiquitin chains serve as a binding scaffold for TAB2/3 and 
mediate TAK1 activation by physically anchoring the TAK1-TAB1 complex thereby inducing its 
activation. TAK1, activates the Iκκ complex, by inducing site specific phosphorylation of IκB 
which signals it for K48-linked ubiquitination and subsequent degradation. Also the activated 
Iκκ complex induces phosphorylation of the P65 subunit and subsequent nuclear translocation, 
where it is responsible for transcription of proinflammatory genes. TLR3 only utilizes the TRIF 
signaling pathway and is activated by recognition of dsRNA or mimetics such as poly I:C. The 
TRIF pathway is also used by TLR4. For TLR4 to use the TRIF signaling pathway it needs the 
bridging protein TRAM whereas TLR3 can bind TRIF directly. The TRIF signaling pathway 
leads to activation of the transcription factor IRF3 as well as late activation of NF-κB and 
MAPKs. Binding of dsRNA by TLR3, TRIF interacts with TRAF3 which leads to activation of 
IKKi, TBK1 and NEMO, resulting in IRF3 phosphorylation, IRF3 dimerization and nuclear 
translocation. This results in IRF3-dependent expression of type 1 IFN genes. TRIF binding to 
TLR4-TRAM or TLR3 can lead to binding and activation of TRAF3, TRAF6, TBK1 and RIP1. 





4 by inducing a trans-autophosphorylation reaction and in turn this induces recruitment and 
activation of IRAK-1 and/or IRAK-2. Together the complex of Myd88/IRAK-4/IRAK-1/2 is 
referred to as the myddosome (Ferrao et al., 2014). Formation of the myddosome results in the 
recruitment and activation of the RING-domain E3 ubiquitin ligase tumor necrosis factor 
receptor-associated factor 6 (TRAF6). Recruitment of TRAF6  induces oligomerization of 
TRAF6, which in conjunction with E2 enzyme Ubc13/Uev1A catalyzes Lys63 (K63)-linked 
ubiquitination of TRAF6 itself and of target proteins IRAK1 and NEMO ( (Ferrao et al., 2012; 
Lamothe et al., 2007). These K63-linked polyubiquitin chains mediate TAK1 activation by 
serving as a binding scaffold for TAB2 or TAB3 which physically anchor the TAK1-TAB1 
complex thereby inducing its activation (Ajibade et al., 2013; Ferrao et al., 2012). The activated 
TAK1-TAB1-TAB2/TAB3 complex, activates the Iκκ complex, a cytoplasmic complex which 
regulates NF-kB signaling by inducing site specific phosphorylation of IκB which tags it for 
K48-linked ubiquitinilation and subsequent degradation. Furthermore, activation of the Iκκ 
complex is involved in the phophorylation of the P65 subunit and subsequent nuclear 
translocation, where it is responsible for transcription of pro-inflammatory genes (Fig.2) 
(Ferrao et al., 2012; Kawai and Akira, 2006; Lu et al., 2008; Yang et al., 2003). In addition to 
MYD88 dependent signaling, TLR4 utilizes the TIR containing adaptor protein TRIF which 
plays a role in activation of the transcription factor IRF3 as well as late activation of NF-κB 
and MAPKs. TRIF signaling through TLR4 occurs through endosomal located TLR4s and 
needs the bridging adaptor protein TRIF related adaptor molecule (TRAM) leading to activation 
of the IRF3 signaling pathway (Kagan et al., 2008). As mentioned before, TLR3 only signals 
through TRIF and contains a direct binding site for TRIF. TRIF -/- transgenic mice show an 
abolished response induced by TLR3 receptor ligand Poly I:C and TLR3 and TLR4 induced 
IRF3 activation and IFN-were absent. In response to TLR4 ligand however, TRIF -/- mice 
showed an impaired pro-inflammatory response but not abolished response, indicating a 
cooperation between the MYD88 and TRIF dependent pathways induced by the activated TLR4 
complex (Yamamoto et al., 2003). Furthermore, TRAM contains a binding motif for TRAF6 
and has the ability to induce p38 MAPK, NF-kB and IFN- through this pathway, showing a 
role beyond just being a bridging protein (Verstak et al., 2014). TRIF contains an -helical N-
terminal domain (TRIF-NTD) which in unstimulated cells blocks the binding sites for 
downstream binding proteins. Upon binding to active TLR4-TRAM or TLR3 it releases the 
inhibititory TRIF-NTD and provides access to the binding sites for downstream signaling 
proteins which are identified to be TRAF3, TRAF6, TBK1 and RIP1 or RIP3 (Gay et al., 2014). 
The latter can both bind directly to the receptor interacting protein (RIP) homotypic interaction 
motif (RIHM) domain located in the C-terminal region of TRIF or is recruited and bound by 
activated TRAF6. Activated RIP1 in turn activates TAK1 induced MAPKs and NF-kB 
activation leading to transcription of pro-inflammatory genes (Cusson-Hermance et al., 2005; 
Kawai and Akira, 2006). For the inductions of type I interferons, TRIF interacts with TRAF3 





induces IRF3 dimerization and translocation resulting in IRF3 dependent expression of type 1 
IFN genes (Fig.2) (Kawasaki and Kawai, 2014; Lu et al., 2008).  
Microglia activation and pathology 
Under normal conditions, microglia are neuroprotective and supportive but in some cases the 
response of microglia can have detrimental effects on its environment. In a normal ‘resting’ 
healthy state of the brain, microglia activity and proliferation are tightly controlled. However, 
long-term changes in the normal physiological state of microglia can occur by transient or 
chronic inflammatory events. This will be exemplified in the coming sections wherein 
microglia responses in pathological scenarios will be discussed. 
 
Ageing and neurodegenerative disease 
 
In particular in the field of ageing and neurodegenerative disease the role of microglia has been 
and still is a subject of debate. Where seemingly contradictory ideas now seem to converge in 
the sense that both over-activation as well as loss of function or dampened responses are both 
prevalent and possibly co-exist during the course of ageing and neurodegenerative events.  
 
 
Concept of microglia priming in ageing and neurodegenerative diseases 
 
Exaggerated activation of microglia is referred to as priming and when primed, microglia are 
more prone to activation and induce an exaggerated inflammatory response upon disturbances 
in their environment (Perry and Holmes, 2014). The phenomenon of microglia priming has 
been addressed in neurodegenerative disease states as well as in normal ageing, the latter being 
one of the main risk factors for neurodegenerative disease. It is well known that during ageing 
the amount of inflammation in the CNS accumulates and cognitive deficits become apparent 
and increase in oxidative stress, lipid peroxidation and accumulation of DNA damage are 
considered as the major hallmarks in the aging brain (Norden et al., 2014a; Norden and 
Godbout, 2013). It is shown across species in humans, rodents and non-human primates, that 
this increase in inflammation is accompanied by microglia specific expression of inflammatory 
markers such as MHC-II, CD11b, CD11c, CD68 and TLRs. Furthermore, ageing is associated 
with a deramified morphology, which is comparable to the activated amoeboid microglial 
morphology and increased mRNA expression of pro-inflammatory genes IL-1, TNF- and 
IL-6 and decreased expression of anti-inflammatory genes TGF- and IL-10 (Norden et al., 
2014b; Norden and Godbout, 2013). A question that arises from these observations is whether 




microglia phenotype and whether or not this phenotype is a causal factor in neurodegenerative 
disease. In ERCC1Δmutant mice, which have an impaired DNA repair system and show 
typical hallmarks of ageing in various tissues including the CNS, microglia which fit the primed 
profile were observed (Raj et al., 2014). In response to an LPS injection, microglia from 
ERCC1Δmice, showed an exaggerated pro-inflammatory response, increased production of 
reactive oxygen species, increased staining of microglia activation marker Mac-2 and further 
increased basal phagocytic activity. Interestingly, when specifically targeting the DNA damage 
to forebrain neurons, microglia priming was restricted to the neocortex, suggesting that an 
affected neuronal environment can induce microglial priming (Raj et al., 2014). 
  
Loss of microglia function in ageing and neurodegenerative diseases 
 
In contrast to these reports on microglia priming, there are also reports showing microglia 
senescence and dystrophy associated with aging and AD. Dystrophic microglia show abnormal 
morphological features such as cytoplasmic fragmentation (cytorrhexis), deramification, 
atrophy, abnormally twisted and tortuous processes and cytoplasmic extensions that can form 
spheroidal swellings near their ends. These morphological changes were thought to indicate 
microglia replicative senescence ultimately leading to microglia degeneration and loss of their 
neuro-protective function. With the current staining protocols morphological identification and 
distiction between activated, phagocytic and dystrophic microglia is possible. (Streit, 2004; 
Streit et al., 2014; Streit and Xue, 2009).  In line with this loss of function hypothesis, recently 
a novel function of microglia has been proposed. In normal healthy brain, microglia envelope 
amyloid plaques with their processes and thereby reduce affinity for soluble forms of Aand 
prevent the formation of protofibrillary Ahotspots. In this way surrounding neurons are 
protected from potentially toxic forms of AHowever, with ageing the envelopment of Aby 
microglia reduces, resulting in more A hotspots and thus increased associated neuritic 
dystrophy. Diminishing of this novel role of microglia in aging and neurodegenerative disease 
is in agreement with a loss of function of microglia (Condello et al., 2015). Previously, impaired 
microglial phagocytosis was observed to be correlated with Aplaque deposition (Krabbe et 
al., 2013). Furthermore, in non-diseased C57BL/6J-Iba1-eGFP mice, it is shown with 2-photon 
microscopy that microglia in aged mice (26-27 months) show significantly reduced surveying 
speed as well as the speed of microglia processes approaching a site of a micro-laser induced 
lesion compared to young adult (11-12 months) mice (Hefendehl et al., 2014). All these 
examples exemplify that aging and neurodegenerative diseases and microglia affect each other. 
And both exaggerated response and loss of specialized functions of microglia can contribute to 






Induction of endotoxin tolerance by previous immune challenges 
 
Peripheral inflammatory events can greatly influence the immune state of the CNS and affect 
neurodegenerative events (Cunningham, 2013; Cunningham et al., 2009; Perry, 2010). Several 
communication pathways between systemic inflammation and neuro-inflammation have been 
identified, which include communication of peripheral inflammation to the brain by neural 
routes, exchange of inflammatory factors through circumventricular organs where the BBB is 
weak or absent, active transport of cytokines across the BBB and secretion of substances by 
cells of the BBB (Quan and Banks, 2007). Not surprisingly, a large part of research in peripheral 
infection focuses on macrophages and monocytes. Although very different than microglia, a lot 
of fundamental processes can be compared between macrophages and microglia cells and 
mechanisms observed in macrophage physiology may hold true for microglia.  
 
Regulation of immune response by endotoxin tolerance 
 
In order for immune cells such as macrophages and microglia to be able to tightly regulate the 
immune response, they can drastically change their responses after previous exposure to 
immune activating microbial agents such as LPS. Endotoxin tolerance (ET), that is described 
as a protective mechanism where innate immune cells enter a state of unresponsiveness after 
being exposed to an endotoxin is one such adaptation. In this way, an exaggerated and possibly 
damaging inflammatory reaction is prevented (Biswas and Lopez-Collazo, 2009). ET was 
already recognized in 1946 by Paul Beeson, when he reported that rabbits show reduced fever 
responses upon daily injections of the typhoid vaccine (Beeson, 1946). ET was later also 
demonstrated in human volunteers inoculated with live salmonella typhosa, which showed 
reduced fever responses upon endotoxin re-challenges (Greisman et al., 1969). ET is not 
restricted to a single pathology and is observed in multiple diseases, e.g. sepsis, cystic fibrosis, 
acute coronary syndrome and cancer (López-Collazo and Del Fresno, 2013). Sepsis is a disease 
state, which is characterized by large scale inflammation in response to a bacterial infection. 
Patients with sepsis experience a severe inflammatory response, also called cytokine storm, 
which is followed by a secondary phase where immune cells have adapted to a transient tolerant 
phenotype and are not able to produce a proper inflammatory response upon an endotoxic 
challenge.  Although the mechanism of ET should serve a protective purpose, it is during this 
immunocompromised phase that patients are more susceptible for infection, leading to 
increased mortality (Biswas and Lopez-Collazo, 2009; López-Collazo and Del Fresno, 2013). 
In relation to effects of sepsis on the CNS, a major symptom is sepsis-associated 
encephalopathy (SAE), which is marked by reduced cerebral blood flow, impaired BBB 
integrity, neuronal damage and microglia activation (Widmann and Heneka, 2014). 
Furthermore, in several animal models of sepsis as well as humans, sepsis has been related to 




hippocampal volume, in the brain (Anderson et al., 2014; Semmler et al., 2013, 2007; Widmann 
and Heneka, 2014). These examples show the magnitude of impact that severe systemic 
inflammation has on the brain. 
 
Mechanism of endotoxin tolerance induction 
 
Reports describing ET and the molecular mechanisms involved in microglia are starting to 
emerge but still are scarce. However, in macrophages and human monocytes ET has been 
described quite extensively.  In response to a second immune challenge, shortly after the first 
challenge, it is generally shown that monocytes and macrophages show downregulation of pro-
inflammatory genes and up regulation of several anti-inflammatory genes and acquire an 
increased capability of phagocytosis (Biswas and Lopez-Collazo, 2009). Regarding the 
induction of endotoxin tolerance by LPS, it has been shown it is dependent on the severity of 
the stimulus. Deng et al (2013) showed that a very low dose of LPS (5-50 pg/ml) primed 
macrophages, whereas a high dose of LPS (10-100 ng/ml) induced a tolerant phenotype in these 
cells. This difference is hypothesized to originate from the differential modulation of the NF-
kB subunit RelB (Deng et al., 2013), RelB has been described as a repressive transcription 
factor for pro-inflammatory genes but is also involved in activation of transcription of NF-kB 
regulator IkB(Chen et al., 2009) . A high dose of LPS initially activates the classical NF-kB 
pathway, including activation of IRAK1 and phosphorylation of P65 and nuclear translocation 
of the p65/p50 heterodimer. Whereas, at the same time, a high dose of LPS also induces 
negative regulatory pathways such as the PI3K pathway involved in suppression of 
IRAK1/TRAF6, upregulation of negative regulator IRAK-M and induction of negative 
transcriptional regulator RelB. In contrast, a super low dose of LPS fails to induce the classical 
NF-kB pathway and no degradation of IRAK-1 and reduction of negative regulator IRAK-M 
were observed. Furthermore, super low dose LPS is hypothesized to induce priming of 
macrophages by reducing RelB through an IRAK-1 and Tollip dependent Tyr16 
phosphorylation of GSK-3, which in turn contributes to phosphorylation of RelB, marking it 
for ubiquitination and proteasomal degradation (Deng et al., 2013). In agreement with these 
observations, endotoxin tolerance in humans injected with LPS (4 ng/kg) is associated with 
decreased levels of IRAK-1 and increased levels of IRAK-M (van ’t Veer et al., 2007). In the 
human promonocyte cell line THP-1, RelB has been identified as a central player in important 
epigenetic mechanisms, which are largely responsible for the induction of the ET phenotype. 






Endotoxin tolerance in microglia 
 
Reports to verify that microglia share these molecular pathways for induction of ET are thus 
far lacking but it is previously reported that microglia display an ET phenotype after a previous 
challenge with LPS. In vitro, after a 24h pretreatment of LPS, primary mouse microglia showed 
a reduced production of pro-inflammatory cytokine IL-6 upon a direct re-stimulation with LPS 
(10 ng/m) compared to non-pretreated microglia (Beurel, 2011). And in organotypic 
hippocampal slice cultures, acute (1 stimulation) and chronic (4 consecutive days of 
stimulation) LPS stimulation induced an ET phenotype of microglia, which showed reduced 
expression of pro-inflammatory cytokines TNF- and IL-6 upon re-stimulation up to 1 week 
after pre-stimulation (Ajmone-Cat et al., 2013). In vivo, intravitreous injection of LPS (1 
mg/ml) 48 prior to experimentally induced retinal ischemia, completely rescued ganglion cells 
by reducing microglia activation (Halder et al., 2013). Furthermore, mice i.p. injected with LPS 
(0.2 mg/kg) 48h before transient middle cerebral artery occlusion were protected against 
ischemic brain injury due to the absence of the microglial inflammatory response that normally 
exacerbates the reaction and damages the tissue (Rosenzweig et al., 2004). Despite these 
protective effects, many questions remain to be answered regarding the biological relevance of 
ET and whether or not it is an adaptive or maladaptive phenomenon, since inflammatory events 




In addition to inflammatory events influencing microglia physiology in adult mice, 
inflammation of the mother during pregnancy can greatly influence both microglia and brain 
function of offspring later at adult life. Bacterial- and viral infection of the mother during 
pregnancy have been identified as major risk factors for the development of neuro-pathologies 
such as autism, schizophrenia and cerebral palsy (Carpentier et al., 2013; Meldrum et al., 2013; 
Patterson, 2011, 2009; Yoon et al., 2000).  
 
Models for mimicking pre- and perinatal inflammation 
 
In order to better understand the effect of prenatal inflammation on neurodevelopment, several 
animal models have been developed where pregnant animals are injected with either live 
bacteria or viral and bacterial molecular mimetics, such as Poly I:C or LPS, respectively 
(Arsenault et al., 2013). In the first place, it should be acknowledged that Poly I:C and LPS 
both induce maternal inflammation, but exert very different effects on the offspring. Where 
LPS injection paradigms induce reduced survival and birth of viable pups, injection of Poly I:C 




in injected dams but other maternal behaviors were not significantly affected. In terms of 
behavioral effects on the offspring, prenatal administration of Poly I:C caused major 
impairments in sensorimotor development whereas prenatal injection of LPS only caused mild 
effects in the offspring. With regards to induced inflammation, both treatments induced a 
similar increase in TNF- and CD68 expression in the fetal brain. The expression of cellular 
markers for astrocytes (GFAP) and neurons (NeuN) in total brain, however, differed after the 
two treatments. Poly I:C did not cause any changes, but LPS exposure reduced the expression 
of these markers 24h post treatment (Arsenault et al., 2013). 
 
Detrimental effect of maternal inflammation on offspring 
 
A large amount of literature is available on the detrimental effects of prenatal inflammation on 
neurodevelopment of the embryo and aberrant behavior of the offspring in various animal 
models including mice, rats, sheep and primates (Boks a, 2010; Wang et al., 2006; Willette et 
al., 2011). One complication though, is the great variability in timing, concentration, 
experimental assessment and type of prenatal immune challenges in the reports (Boksa, 2010). 
Since behavioral and developmental effects on offspring induced by prenatal immune 
challenges depend on the timing during pregnancy and severity of the challenge (Meyer et al., 
2007), it is difficult to pin point specific effects caused by maternal inflammation. However, 
some general changes are observed, such as decreased prepulse inhibition behaviour and 
impairments in learning and memory (Boksa, 2010). In addition, to complicate the issue further, 
differences were observed between neonatal- and adult offspring, born to dams subjected to the 
same LPS paradigm. For example, late, low grade maternal inflammation induced by injection 
of low dose LPS (0.01 mg/kg) at GD15 exacerbated damage induced by hypoxia-ischemia in 
neonates whereas it had protective effects in adult animals (Wang et al., 2007). Taken together, 
it has been well established in the past decades that prenatal inflammation severely impacts 
behavioral and neurodevelopmental processes and impairs learning and memory. But 
information about mechanisms and the role of specific cell types, such as microglia, underlying 
these events has just started surfacing. 
 
Role of microglia in maternal inflammation  
 
It has been shown that microglia play an important role in neurogenesis during both embryonic 
development and postnatal life. Neurogenesis has to be tightly regulated, since an excess or 
diminishment of neural precursor cells and neurons can have profoundly negative effects on 
neurodevelopment and function of the brain (Sato, 2015). This is particularly evident in areas 
such as the hippocampus and prefrontal cortex, that are implicated in learning and memory and 





microglia activation and the subsequent release of pro-inflammatory cytokines and free radicals 
leads to decreased neurogenesis eventually contributing to the pathophysiology of 
schizophrenia (Monji et al., 2009). In contrast, excessive neurogenesis is hypothesized to be 
involved in the pathology of autism (Wegiel et al., 2010). In rodents, monkeys and humans, 
microglia colonize the neural proliferative zones of the neocortex during late stages of cortical 
neurogenesis. They are involved in phagocytosing neural precursor cells pre- and postnatal, and 
as such determine the number of mature neurons. Increasing or decreasing microglia activation, 
during development causes a decrease or increase in number of neural precursor cells, 
respectively (Cunningham et al., 2013). Furthermore, Squarzoni et. al. (2014) showed that 
microglia are involved in the wiring of neuronal circuits in the forebrain. Prenatal activation of 
microglia by injection of LPS in pregnant mice at E13.15, negatively affected dopaminergic 
axon outgrowth and positioning of neocortical interneurons, which are both linked to 
neuropsychiatric disorders (Squarzoni et al., 2014).  Above discussed examples show the direct 
detrimental impact of microglia activation during pregnancy but long-term changes and effects 
of secondary immune challenges in offspring later in life remain to be explored.  
 
Maternal inflammation and focus on the hippocampus 
 
Graciarena et al (2013) showed that prenatal inflammation reduced neurogenesis in the dentate 
gyrus for at least 60 days after birth, in which persistent microglia activation was observed in 
the dentate gyrus (Graciarena et al., 2013). The cytokine IL-1 is necessary for normal 
hippocampus-dependent learning and memory since inhibition of IL-1 expression or treatment 
with an antagonist in the hippocampus impaired learning and memory (Goshen et al., 2007). In 
rats, perinatal infection with E. coli did not change contextual learning. However, i.p. injection 
with LPS (25 g/kg) induced impaired learning due to exaggerated production of IL-1 by 
microglia. This effect was not observed when IL-1synthesis was prevented by caspase 1 
inhibition (Bilbo, 2005; Bilbo et al., 2005). In addition, decreased levels of BDNF were 
observed in hippocampal tissue (Bilbo et al., 2005; Bilbo and Schwarz, 2009a; Williamson et 
al., 2011).  The importance of microglia-derived BDNF in learning and memory was recently 
shown by Parkhurst et. al. (2013), who showed that both microglia depletion as well as specific 
removal of microglia-derived BDNF resulted in impaired learning and learning-induced 
synapse formation (Parkhurst et al., 2013). So far, most research concerning this topic has 
focused on hippocampus and hippocampal microglia populations showing robust changes in 
offspring microglia after prenatal inflammation. Taking in mind that microglia show regional 
differences in the brain (Grabert et al., 2016), effects of prenatal inflammation in microglia 





High fat diet induced inflammation 
 
Diet, especially the western high-fat high-carbohydrate diet, has been implicated in chronic low 
grade inflammation and is associated with obesity, diabetes mellitus type 2, cardiovascular 
disease, arthritis, cancer and neurodegenerative disease (Huang et al., 2013; Ruiz-Nuñez et al., 
2013).  As discussed earlier, systemic and CNS inflammation are tightly linked to each other, 
and indeed high fat diet has been shown to highly affect brain homeostasis  and function. High 
fat diet induced cognitive impairment together with increased inflammatory markers, decreased 
levels of BDNF and increased microglia activation in the CNS of mice (Pistell et al., 2010). 
Also in humans there is evidence that high fat diet has detrimental effects on cognition (Francis 
and Stevenson, 2013). Activation of the NF-kB inflammatory pathway plays a central role in 
promoting metabolic diseases, affecting the overall human body including the CNS, and is 
activated by over nutrition and an excess of free fatty acids in a high fat diet (Baker et al., 2011). 
Metabolic syndrome is a collection of pathologic metabolic features including obesity, impaired 
glucose tolerance, insulin resistance, hyperlipidemia and high blood pressure and over-nutrition 
has been recognized as the main environmental factor triggering metabolic inflammation (Cai 
and Liu, 2012; Tang et al., 2015). 
 
Central role of the hypothalamus 
 
In the brain, the hypothalamus is the key region in regulating energy homeostasis controlling 
hunger and thermal regulation. The most important signaling hormones in this respect are leptin 
and insulin, which mainly act through two subpopulations of neurons in the arcuate nucleus,  
These two subpopulations are 1) POMC and CART neurons which have an anorexigenic effect, 
activation and secretion of neuropeptides from them decrease food intake and 2) AgRP and 
NPY neurons which have an orexigenic effect and thus signal for increased food intake upon 
activation (Coll et al., 2007; Varela and Horvath, 2012). AgRP and NPY neurons are inhibited 
by leptin whereas POMC and CART neurons are stimulated by it. Low levels of leptin and 
insulin set in motion pathways that induce hunger signals and decrease energy expenditure. 
When food intake has restored energy resources, returning levels of leptin and insulin inhibit 
AgRP and NPY neurons and stimulate POMC and CART neurons (De Souza et al., 2005; 
Varela and Horvath, 2012). Inflammation in the medio-basal hypothalamus (MBH), in 
particular the arcuate nucleus and basal eminence, disrupts these food regulating pathways 
leading to the detrimental metabolic features observed in metabolic syndrome (Cai and Liu, 
2012; De Souza et al., 2005; Tang et al., 2015). The severe impact of high fat diet (HFD), 
leading to metabolic syndrome, is shown in rat and mouse diet-induced obesity (DIO) models, 
where already 24h after HFD, upregulation of inflammatory markers in the hypothalamus is 





until 4 weeks. After 8 weeks of HFD feeding, a significant accumulation of astrocytes and 
microglia showing activated morphology was observed in the Arc-ME region, and this feature 
was positively correlated with weight gain (Thaler et al., 2012; Valdearcos et al., 2014). This 
rapid induction of reactive gliosis is shown to be caused by neuronal injury in the Arc-me area. 
Whereas this first transient glia response limits injury, upon a prolonged time period chronic 
inflammation and neuronal loss is observed. In agreement with these results in rat and mice, in 
obese humans, gliosis has been observed in the hypothalamus using MRI techniques (Thaler et 
al., 2012). Both microglia and astrocytes show accumulation in the MBH after initiation of 
HFD. However, only microglia initiate an inflammatory response in reaction to the buildup of 
saturated fatty acids (SFAs) in the hypothalamus. This gave rise to the hypothesis that microglia 
orchestrate the inflammatory response in the hypothalamus during HFD, leading to neuronal 
distress and followed by detrimental consequences. In support of this hypothesis, SFAs were 
shown to potently activate microglia but not astrocytes in vitro. Furthermore, increasing or 
depleting microglia in the MBH in vivo augmented or decreased hypothalamic inflammation, 
respectively. Remarkably, when microglia were depleted from the hypothalamus, the induction 
of neuronal stress was nearly abolished. Whereas, when microglia numbers were increased, the 
area affected was extended to hypothalamic areas outside the Arc-ME region (Valdearcos et 
al., 2014). This places microglia in the center of attention in diet-induced chronic inflammation, 
possibly leading to pathologies such as metabolic syndrome.  
Epigenetic regulation of phenotype 
As discussed previously, microglia are equipped with a large variety of receptors to recognize 
threats and respond in a tailored way to effectively resolve potentially dangerous situations. For 
this response to be specific, PRRs recognize molecular patterns and set in motion the proper 
signaling pathways to recruit specific transcription factors and induce transcription of genes 
that fit the situation. Such pathways can be regulated by short term mechanisms, for example 
TLR4 receptor internalization. On the long-term, these pathways are regulated by very stable 
and long-term epigenetic modifications of the genome. Keeping in mind that these are very 
stable changes and the microglial population renews itself without contribution of non-
microglial cells and at a very slow rate of around 28% every year (Askew et al., 2017; Réu et 
al., 2017), epigenetic changes can have implications for considerable amounts of time. 
The DNA of eukaryotic cells is packaged into chromatin, with nucleosomes as basic units. 
Nucleosomes consist of an octameric protein complex containing two sets of four histone 
proteins, namely H2A, H2B, H3 and H4. Around this octameric complex, 146 base pairs of 
DNA are wrapped twice, from which amino-terminal histone tails protrude. On their turn, 
nucleosome are organized in higher structures stabilized by histone linker protein H1, 




is defined as modifications in the form of covalent and post translational changes to DNA, 
histones and chromatin associated proteins, without changing the DNA sequence itself. Rather 
it induces conformational changes in the chromatin shaping it in to a more closed 
(heterochromatin) or open (euchromatin) structure, making it more inaccessible or accessible, 
respectively for transcription. The importance of epigenetics is emphasized by the fact that it 
can direct cells towards diverse differentiation pathways and cell functions(Kondilis-Mangum 
and Wade, 2012; Mehta and Jeffrey, 2015). Main epigenetic mechanisms are DNA methylation, 
histone tail modifications and post transcriptional regulation of gene expression by short non 
coding mRNAs called micro RNAs (miRNAs). Since in this doctoral dissertation, the focus 
was mainly on histone tail modifications, these only will be discussed in the next section.  
 
Histone tail modifications 
 
Existence of histone posttranslational modifications (PTMs) have been known ever since 
Allfrey et al. in 1964, reported on histone acetylation and methylation in vitro in calf thymus 
(Allfrey et al., 1964).  In 2001 Jenuwein and Allis proposed the histone code hypothesis 
(Jenuwein and Allis, 2001). This hypothesis stated that PTMs considerably extend the  
information potential by modulating accessibility, and thus transcriptional changes due to 
changes in chromatin structure. For transcription these PTMs were considered of equal 
importance as the nucleotide sequence (Jenuwein and Allis, 2001). Ever since, intensive 
research on this subject has greatly extended our knowledge on the importance and influence 
of histone PTMs on regulation of gene expression. All histones in the nucleosome can be 
modified and generally these modifications take place at the protruding histone tails. Such 
modifications can directly influence chromatin structure or exert their effect by acting as a 
binding dock for forming specific regulatory protein complexes (Rothbart and Strahl, 2014). In 
recent years a variety of PTMs have been identified, including acetylation, methylation, 
phosphorylation, citrullination, ubiquitination, sumoylation, ADP-ribosylation and proline 
isomerization (Rothbart and Strahl, 2014). Although there is a large diversity in PTMs, in 
general active and silenced chromatin is characterized by certain patterns of PTMs. For 
example, high lysine acetylation levels of histones H3 and H4 and trimethylation of lysine 4 of 
H3 (H3K4me3) are generally associated with active genes. Whereas trimethylation of histone 
H3 lysine 27 (H3K27me3) and di- and trimethylation of lysine 9 (H3K9me3) are generally 
associated with repressed gene expression (Barski et al., 2007; Zhang et al., 2015). So far, there 
have been few reports investigating histone modifications in microglia activation. Recently, 
Chauhan et al. (2015) showed that upon the parasitic brain disease neurocysticercosis helminth 
parasites induce immune suppression in microglia via an epigenetic mechanism. Cultured 
primary microglia were treated with helminth soluble factors (HSF) and showed 





precipitation (ChIP) assays it was shown that HSF significantly decreased recruitment of RNA 
polymerase II to pro-inflammatory promotor regions of IL6, TNF-NOS2 and MHC-II. More 
specifically, HSF downregulated activation mark H3K9/14Ac and significantly inhibited LPS-
induced increased appearance of the activation marks H3K9/14Ac and H3K4me3 at the above 
mentioned pro-inflammatory promotor regions (Chauhan et al., 2015). Thus far, research on 
histone modifications in macrophages and monocytes has received more attention than in 
microglia. Regarding the ET phenotype that has been discussed previously, a detailed 
epigenetic mechanism has been described. In LPS tolerized human promonocytes, reduced 
transcription of TNF- was accompanied by enriched H3K9me2 on nucleosomes associated 
with the TNF- promotor region. An interesting finding of this study was a link between histone 
H3K9me2 and TNF- promotor CpG methylation. In the proposed model, recruited histone 
methyl transferase G9a induces demethylation of H3K9, which creates a binding site for 
chromatin modifier heterochromatin-binding protein 1 (HP1). HP1 in turn recruits Dnmt3a/b 
methyltransferase, which methylates nearby CpG islands at the TNF- promotor (El Gazzar et 
al., 2008, 2007).  Later, it was found that RelB is one of the primary responsible elements in 
establishment of this epigenetic silencing mechanism. It was previously shown that even though 
the transcription activating NF-kB subunit p65 was present in the nucleus in tolerized cells, it 
could not bind to the IL-1 and the TNF-promotor due to negative feedback expression of 
RelB (El Gazzar et al., 2007; Yoza et al., 2006). Furthermore, upon ET in macrophages, 
expression of RelB was reported to be of key importance for pro-inflammatory gene silencing 
(Deng et al., 2013). RelB was identified as the key initiator of epigenetic silencing in the ET 
phenotype of THP-1 cells, by recruiting and directly interacting with G9a, thereby starting the 
above mentioned cascade (Chen et al., 2009). During this process H3K9me2 induced 
recruitment of high mobility group box 1 protein (HMBG1) and linker histone protein 1 (H1) 
to the repressive complex, where they interact with RelB, thereby stabilizing the repressive 
complex (El Gazzar et al., 2009). In addition, in human primary monocytes, a mechanism that 
inhibits tolerization, mediated by Type II IFN, IFN- has been reported. Pretreatment with IFN-
 inhibited LPS-induced tolerization of human primary monocytes, which after treatment 
showed comparable levels of transcription of pro-inflammatory genes in response to LPS 
compared to naïve cells. This inhibition of tolerance by IFN- was reported to involve the 
recruitment of a protein called Brg-1, inducing remodeling of chromatin to make it accessible 
again for transcription factors (Chen and Ivashkiv, 2010). Recently, a tolerance antagonizing 
action of type I IFN, interferon, was shown as well. Pretreatment with interferon 
restored the LPS-induced transcription of the pro-inflammatory genes TNF-IL-1 and IL6. 
Furthermore, it was observed that pretreatment with interferon significantly increased 
enrichment of H3K4me3, generally associated with activation, at the promotor regions of these 
pro-inflammatory genes (Shi et al., 2015). These examples show that the orchestration of the 




chromatin remodeling and concerns a complex interplay of antagonizing mechanisms which is 
far from solved and is an important future point of investigation in microglia as well. 
 
Figure 3 Three main epigenetic mechanisms. Epigenetics are defined as modifications in the form of 
covalent and posttranslational changes to DNA, histones and chromatin associated proteins, without 
changing the DNA sequence itself. Epigenetics is regulated in several stages. Our DNA is compacted 
into chromosomes where our DNA is wound around octameric histone complexes. Histone proteins 
extend histone tails, on which posttranslational modifications (PTMs) can take place. PTMs can 
modify structure making the DNA strand more inaccessible or accessible for the transcription 
machinery. Examples of PTMs are H3K4 trimethylation (H3K4me3) and acetylation of H3K9 (AcH3K9) 
which are associated with active gene transcription and H3K27 trimethylation (H3K27me3) which is 
associated with repressed gene expression. miRNAs are a family of small single stranded RNA 
fragments of approximately 21 nucleotides. These miRNAs are involved in gene regulation which 
takes place post transcriptional, where they bind and inhibit translation by the ribosomal machinery 
or induce degradation of mRNA. DNA methylation is mainly described as the process of methylation 
of CpG rich regions called CpG islands in or near regions of transcription starts sites involved in stable 





Outline of this thesis 
In this thesis the central theme addresses microglia imprinting by previous inflammatory 
challenging. It has been a journey from a fundamental molecular view on microglia adaptation 
after inflammatory challenges, up to the role of our diet and its influence on microglia responses 
and how we can identify and possibly use dietary components to modulate microglia responses. 
 
In chapter 2, we set out to characterize the inflammatory microglia response after a previous 
inflammatory challenge. In the literature, this mechanism has been described in detail in 
peripheral macrophages and monocytes, showing that these cells enter a short transient tolerized 
state in order to prevent an exacerbated inflammatory response. Suggested mechanisms for this 
induced tolerance involve epigenetic changes. Thus far, it was unknown whether or not 
microglia respond in a similar way to previous inflammatory challenges. This information is of 
vital importance since microglia, in contrast to peripheral macrophages and monocytes, are long 
lived cells and stable epigenetic changes can thus have long-term effects. In order to investigate 
if microglia show a stable tolerized phenotype in adult mice, we have set up a repetitive LPS 
stimulation paradigm with intervals between stimulations up to 7 days in vitro and up to 4 
months in vivo. These intervals were considerably longer than any experiment described in the 
current literature. We have indeed observed stable and long-term changes in microglia response 
after previous inflammatory challenges. We have described these changes at transcriptional, 
translational and epigenetic levels and shown its implications for learning using the T-maze 
behavioral paradigm. Although further research is needed we have proposed a long-term 
regulatory mechanism in microglia using these LPS treatment paradigms. 
 
In addition to the observed effects in adult mice, in chapter 3 we described effects of prenatal 
inflammation. Since microglia colonize the CNS during early embryonic development 
(Ginhoux et al., 2013), inflammation transmitted from the mother to the embryo possibly affects 
the microglia of the offspring later in life. This effect, most likely is mediated by stable 
epigenetic changes similar to those described in chapter 2. To assess possible effects of prenatal 
inflammation, we used an LPS injection paradigm of three consecutive LPS injections during 
the last stage of pregnancy. We showed that inflammation of the mother, induced by LPS, has 
long-term effects on the microglia gene expression response upon LPS treatment in offspring 
up to 4 months after birth. In the same mice we showed that this response has a different nature 
in hippocampus compared to the rest of the brain. LPS injection caused significant detrimental 
changes in behavioral and learning and memory tests in the offspring. In agreement with 
literature that describe mechanisms of involvement of microglia in learning and memory, we 
collected data that suggest that prenatal inflammation affects microglia of offspring in such a 




In chapter 4, microglia were evaluated in an environment of chronic peripheral inflammation 
induced by a high fat diet. In this report, research of the effect of HFD was taken to another 
level by combining it with physiological ageing. In the literature, ageing has been described as 
a factor that can induce immune priming of microglia as well as microglia dystrophy (Perry and 
Holmes, 2014; Streit, 2004; Streit et al., 2014; Streit and Xue, 2009). It is generally accepted 
that upon ageing microglia negatively impact brain homeostasis and contribute to 
neurodegenerative pathology. In chapter 4 the effects of long-term exposure to HFD have been 
studied. Because of this, results presented may seem contradictory with present literature on 
short-term HFD exposure in the hypothalamus, the main region involved in energy homeostasis 
regulation. Most importantly, we showed that diet can greatly influence ageing-induced 
microglia activation state in white matter regions, augmenting white matter pathology observed 
in ageing. 
In chapter 5 we set out to generate a microglia NF-kB reporter cell line. This cell line provides 
the possibility to do large screening assays of possible anti-inflammatory effects on microglia. 
Here we describe the generation of a NF-B luciferase reporter system transfected in an 
immortalized BV2 microglial cell line. We used this cell line to screen a number of selected 
anti-inflammatory food components and provided a ‘proof of concept’ by validating in detail 
one of the candidates that was identified using this in vitro screening method. This candidate 
(magnesium sulfate) reduced the LPS-induced inflammatory response in primary mouse 
microglia in vitro, as well as prevent the establishment of a tolerant phenotype of the BV2 NF-
B luciferase reporter cell line. 
In chapter 6, the research presented in chapter 2-5 is discussed and future perspectives and 
research possibilities are addressed. A central theme in this discussion is the question what the 
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